4//SEC Filing
Ho Carole 4
Accession 0001714899-24-000194
CIK 0001714899other
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:14 PM ET
Size
11.0 KB
Accession
0001714899-24-000194
Insider Transaction Report
Form 4
Ho Carole
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-08-20$23.79/sh−2,453$58,357→ 138,815 total - Sale
Common Stock
2024-08-21$24.41/sh−14,098$344,132→ 124,717 total - Sale
Common Stock
2024-08-21$24.96/sh−5,907$147,439→ 118,810 total
Holdings
- 25,000(indirect: See footnote)
Common Stock
- 183,219(indirect: See footnote)
Common Stock
Footnotes (8)
- [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
- [F2]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.62 to $23.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]Includes 118,810 Unvested RSUs.
- [F4]The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted September 29,2023.
- [F5]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $23.84 to $24.83 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F6]The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $24.84 to $25.21 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F7]The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee.
- [F8]The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.
Documents
Issuer
Denali Therapeutics Inc.
CIK 0001714899
Entity typeother
Related Parties
1- filerCIK 0001724605
Filing Metadata
- Form type
- 4
- Filed
- Aug 21, 8:00 PM ET
- Accepted
- Aug 22, 4:14 PM ET
- Size
- 11.0 KB